It seems that the prevalence of gastrointestinal symptoms in coronavirus disease 2019 (COVID-19) patients is around 10%, and it is following an increasing trend[ 43 , 44 ].
← all excerpts
Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review.
1
—
—